Inventor
BABU YARLAGADDA S
US75 patents
⚠️ This page may combine multiple inventors who share the name “BABU YARLAGADDA S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOCRYST PHARM INC
45 patentsUS10329260B2Jun 25, 2019
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC26 citations98
US10125102B2Nov 13, 2018
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC24 citations98
US7560434B2Jul 14, 2009
AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
BIOCRYST PHARM INC92 citations97
US7514410B2Apr 7, 2009
Hepatitis C therapies
BIOCRYST PHARM INC80 citations97
US6699994B1Mar 2, 2004
Biaryl compounds as serine protease inhibitors
BIOCRYST PHARM INC87 citations97
US7994139B2Aug 9, 2011
Antiviral therapeutic agents
BIOCRYST PHARM INC81 citations95
US6653340B1Nov 25, 2003
Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
BIOCRYST PHARM INC88 citations95
US10662160B1May 26, 2020
Crystalline salts of a plasma kallikrein inhibitor
BIOCRYST PHARM INC17 citations94
US6562861B1May 13, 2003
Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
BIOCRYST PHARM INC31 citations93
US5602277AFeb 11, 1997
Substituted benzene derivatives useful as neuraminidase inhibitors
BIOCRYST PHARM INC33 citations93
US11117867B2Sep 14, 2021
Crystalline salts of a plasma kallikrein inhibitor
BIOCRYST PHARM INC8 citations92
US10689346B2Jun 23, 2020
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC10 citations92
US10633345B2Apr 28, 2020
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC10 citations92
US7388002B2Jun 17, 2008
Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
BIOCRYST PHARM INC39 citations92
US6936719B2Aug 30, 2005
Biaryl compounds as serine protease inhibitors
BIOCRYST PHARM INC37 citations92
US6503745B1Jan 7, 2003
Cyclopentane and cyclopentene compounds and use for detecting influenza virus
BIOCRYST PHARM INC42 citations92
US12344585B2Jul 1, 2025
Crystalline salts of a plasma kallikrein inhibitor
BIOCRYST PHARM INC6 citations86
US11618733B2Apr 4, 2023
Crystalline salts of a plasma kallikrein inhibitor
BIOCRYST PHARM INC7 citations86
US11708332B2Jul 25, 2023
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations84
US11708333B2Jul 25, 2023
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations84
US11230530B2Jan 25, 2022
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC5 citations84
US11203574B2Dec 21, 2021
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC5 citations84
US11192861B2Dec 7, 2021
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC5 citations84
US10420769B2Sep 24, 2019
Methods and compositions for inhibition of polymerase
BIOCRYST PHARM INC4 citations84
US10022375B2Jul 17, 2018
Methods and compositions for inhibition of polymerase
BIOCRYST PHARM INC5 citations84
US9492452B2Nov 15, 2016
Methods and compositions for inhibition of polymerase
BIOCRYST PHARM INC9 citations84
US6518299B1Feb 11, 2003
Substituted pyrrolidine compounds useful as neuraminidase inhibitors
BIOCRYST PHARM INC13 citations84
US6410594B1Jun 25, 2002
Substituted cyclopentane compounds useful as neuraminidase inhibitors
BIOCRYST PHARM INC14 citations84
US11370774B2Jun 28, 2022
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC4 citations83
US11021458B2Jun 1, 2021
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC5 citations83
US12162838B2Dec 10, 2024
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC0 citations73
US12116346B2Oct 15, 2024
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC0 citations73
US11685721B2Jun 27, 2023
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations73
US11559515B2Jan 24, 2023
Indole compounds and analogues thereof
BIOCRYST PHARM INC2 citations73
US11173159B2Nov 16, 2021
Methods and compositions for inhibition of polymerase
BIOCRYST PHARM INC3 citations73
US10849883B2Dec 1, 2020
Benzopyrazole compounds and analogues thereof
BIOCRYST PHARM INC3 citations73
US10562850B2Feb 18, 2020
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations73
US12043610B2Jul 23, 2024
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC1 citations72
US11866418B2Jan 9, 2024
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC2 citations72
US11708347B2Jul 25, 2023
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC3 citations72
US11661426B2May 30, 2023
Imidazole-containing inhibitors of ALK2 kinase
BIOCRYST PHARM INC2 citations72
US9770427B2Sep 26, 2017
Antiviral treatments
BIOCRYST PHARM INC3 citations71
US12590068B2Mar 31, 2026
Crystalline salts of a plasma kallikrein inhibitor
BIOCRYST PHARM INC0 citations62
US12590069B2Mar 31, 2026
Crystalline salts of a plasma kallikrein inhibitor
BIOCRYST PHARM INC0 citations62
US12552750B2Feb 17, 2026
Crystalline salts of a plasma kallikrein inhibitor
BIOCRYST PHARM INC0 citations62
BABU YARLAGADDA S
4 patentsUS8242085B2Aug 14, 2012
Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
BABU YARLAGADDA S81 citations97
US8440813B2May 14, 2013
Antiviral nucleoside analogs
BABU YARLAGADDA S42 citations93
US8163703B2Apr 24, 2012
Hepatitis C therapies
BABU YARLAGADDA S27 citations91
US8133870B2Mar 13, 2012
Therapeutic furopyrimidines and thienopyrimidines
BABU YARLAGADDA S32 citations91
(unassigned)
1 patentShowing the top 50 of 75 patents by PatentIndex Score.